Biopixlar
Featured
Can Fluicell’s Bioprinted Tissue Help Treat Type 1 Diabetes?
As Swedish bioprinter manufacturer Fluicell prepares to enter the regenerative medicine market through its BioRej Advance program, it focuses on developing therapeutic products based on bioprinted transplantable microtissues targeting important…
Interview with Gavin Jeffries from Fluicell: “Cell Biology is at the Core of our Work”
Getting to know cells well helps understand how organisms function. This is one of the aspects that drive scientists, researchers, and physicians to create bioprinting technology to generate living structures…
Fluicell is Preparing to be the Next Big Player in Sweden’s Bioprinting Field
Creating innovative tools and high-tech systems for life science researchers around the globe has turned up some fascinating new companies in the last few years; and with Europe currently housing…
